Biodistribution and dosimetry studies for the optimization of pre-targeted radionuclide therapy using 211At-labeled modified biotin

被引：0
|
作者：
Ukon, N. [1 ]
Washiyama, K. [1 ]
Sugiyama, A. [2 ]
Zhao, S. [1 ]
Tatsumi, T. [2 ]
Aoki, M. [1 ]
Yamatsugu, K. [2 ]
Nishijima, K. [1 ]
Shimoyama, S. [1 ]
Tan, C. [1 ]
Joho, T. [1 ]
Oriuchi, N. [1 ]
Kanai, M. [2 ]
Takahashi, K. [1 ]
Kodama, T. [2 ]
机构：
[1] Fukushima Med Univ, Fukushima, Japan
[2] Univ Tokyo, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-115
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 14 条
  • [1] 211At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer
    Shi, Xiumin
    Li, Qing
    Zhang, Lulu
    Hanyu, Masayuki
    Xie, Lin
    Hu, Kuan
    Nagatsu, Kotaro
    Zhang, Chuan
    Wu, Zhengcan
    Wang, Feng
    Zhang, Ming-Rong
    Yang, Kai
    Zhu, Ran
    BIOCONJUGATE CHEMISTRY, 2021, 32 (08) : 1763 - 1772
  • [2] Targeted Alpha Therapy of Glioma Using 211At-Labeled Heterodimeric Peptide Targeting Both VEGFR and Integrins
    Liu, Weihao
    Ma, Huan
    Liang, Ranxi
    Chen, Xijian
    Li, Hongyan
    Lan, Tu
    Yang, Jijun
    Liao, Jiali
    Qin, Zhi
    Yang, Yuanyou
    Liu, Ning
    Li, Feize
    MOLECULAR PHARMACEUTICS, 2022, 19 (09) : 3206 - 3216
  • [3] Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model
    Gaschet, J.
    Echeynne, R.
    Chouin, N.
    Gazzola, S.
    Guerard, F.
    Gouard, S.
    Marionnaud-Lambot, S.
    Maubert, A.
    Alliot, C.
    Hofgaard, P. O.
    Bogen, B.
    Yan, E.
    Haddad, F.
    Kraeber-Bodere, F.
    Wheatcroft, M.
    Gestin, J.
    Cherel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S39 - S40
  • [4] Radiolabeling and biodistribution in the tumor xenograft of 211At-labeled anti-CXCR4 antibody for cancer stem cell targeted alpha-particle therapy
    Oriuchi, N.
    Zhao, S.
    Aoki, M.
    Tan, C.
    Sugawara, S.
    Nishijima, K.
    Shimoyama, S.
    Washiyama, K.
    Takahashi, K.
    Ikezoe, T.
    Ito, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S702 - S703
  • [5] Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine:: Evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy
    Lindegren, S
    Andersson, H
    Jacobsson, L
    Bäck, T
    Skarnemark, G
    Karlsson, B
    BIOCONJUGATE CHEMISTRY, 2002, 13 (03) : 502 - 509
  • [6] Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403
    Ling, Xiaoxi
    Latoche, Joseph D.
    Choy, Cindy J.
    Kurland, Brenda F.
    Laymon, Charles M.
    Wu, Yijen
    Salamacha, Nathan
    Shen, Ding
    Geruntho, Jonathan J.
    Rigatti, Lora H.
    Windish, Hillarie P.
    Langton-Webster, Beatrice
    Berkman, Clifford E.
    Anderson, Carolyn J.
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (02) : 274 - 284
  • [7] Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403
    Xiaoxi Ling
    Joseph D. Latoche
    Cindy J. Choy
    Brenda F. Kurland
    Charles M. Laymon
    Yijen Wu
    Nathan Salamacha
    Ding Shen
    Jonathan J. Geruntho
    Lora H. Rigatti
    Hillarie P. Windish
    Beatrice Langton-Webster
    Clifford E. Berkman
    Carolyn J. Anderson
    Molecular Imaging and Biology, 2020, 22 : 274 - 284
  • [8] PRE-TARGETED IMMUNOSCINTIGRAPHY IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCC) USING STREPTAVIDIN CONJUGATED HMFG1 AND INDIUM-111-LABELED BIOTIN
    KALOFONOS, HP
    HNATOWICH, DJ
    RUSCHOWSKI, M
    SNOOK, D
    SIVOLAPENKO, GB
    LAVENDER, JP
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 318 - 318
  • [9] Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
    Baum, Richard P.
    Schuchardt, Christiane
    Singh, Aviral
    Chantadisai, Maythinee
    Robiller, Franz C.
    Zhang, Jingjing
    Mueller, Dirk
    Eismant, Alexander
    Almaguel, Frankis
    Zboralski, Dirk
    Osterkamp, Frank
    Hoehne, Aileen
    Reineke, Ulrich
    Smerling, Christiane
    Kulkarni, Harshad R.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 415 - 423
  • [10] Fibroblast activation protein-targeted radionuclide therapy of solid tumors using [177Lu]Lu-DOTAGA-Glu-(FAPi)2: biodistribution and dosimetry
    Kurth, Jens
    Krause, Bernd
    Lanzafame, Helena
    Joksch, Markus
    Fendler, Wolfgang
    Herrmann, Ken
    Roesch, Frank
    Heuschkel, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12